EUVIMEDEUVIMED entdecken
Crossref

Comparison of Aflibercept and Brolucizumab in Treatment-Naïve Neovascular Age-related Macular Degeneration with Thick Pigment Epithelial Detachments

In Gyeong Lee, Hoon Dong Kim, In Hwan Cho, Chang Hwan Lee

Korean Journal of Ophthalmology · 09.11.2026

DOI: 10.3341/kjo.2026.0032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Korean Journal of Ophthalmology, online erschienen am 09.11.2026. Verfasst von In Gyeong Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, College of Medicine, Soonchunhyang University, Cheonan, Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AfliberceptBrolucizumabNeovascular age-related macular degenerationPigment epithelial detachments

Autor:innen und Institutionen

  • Department of Ophthalmology, College of Medicine, Soonchunhyang University, Cheonan, Korea.
  • Department of Ophthalmology, College of Medicine, Soonchunhyang University, Cheonan, Korea. pps333@naver.com.

Zitieren

APA

Lee, I. G., Kim, H. D., Cho, I. H., & Lee, C. H. (2026). Comparison of Aflibercept and Brolucizumab in Treatment-Naïve Neovascular Age-related Macular Degeneration with Thick Pigment Epithelial Detachments. Korean Journal of Ophthalmology. https://doi.org/10.3341/kjo.2026.0032

Vancouver

Lee IG, Kim HD, Cho IH, Lee CH. Comparison of Aflibercept and Brolucizumab in Treatment-Naïve Neovascular Age-related Macular Degeneration with Thick Pigment Epithelial Detachments. Korean Journal of Ophthalmology. 2026. doi:10.3341/kjo.2026.0032

BibTeX
@article{Lee2026,
  author = {Lee, In Gyeong and Kim, Hoon Dong and Cho, In Hwan and Lee, Chang Hwan},
  title = {Comparison of Aflibercept and Brolucizumab in Treatment-Naïve Neovascular Age-related Macular Degeneration with Thick Pigment Epithelial Detachments},
  journal = {Korean Journal of Ophthalmology},
  year = {2026},
  doi = {10.3341/kjo.2026.0032}
}
Kostenlos starten →